Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Antibiotics Enhance Prevention and Eradication Efficacy of Cathodic-Voltage-Controlled Electrical Stimulation against Titanium-Associated Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Biofilms.

Canty MK, Hansen LA, Tobias M, Spencer S, Henry T, Luke-Marshall NR, Campagnari AA, Ehrensberger MT.

mSphere. 2019 May 1;4(3). pii: e00178-19. doi: 10.1128/mSphere.00178-19.

2.

Draft Genome Sequence of Pediatric Otitis Media Isolate Streptococcus pneumoniae Strain EF3030, Which Forms In Vitro Biofilms That Closely Mimic In Vivo Biofilms.

Scott EJ 2nd, Luke-Marshall NR, Campagnari AA, Dyer DW.

Microbiol Resour Announc. 2019 Jan 10;8(2). pii: e01114-18. doi: 10.1128/MRA.01114-18. eCollection 2019 Jan.

3.

Streptococcus pneumoniae Modulates Staphylococcus aureus Biofilm Dispersion and the Transition from Colonization to Invasive Disease.

Reddinger RM, Luke-Marshall NR, Sauberan SL, Hakansson AP, Campagnari AA.

MBio. 2018 Jan 9;9(1). pii: e02089-17. doi: 10.1128/mBio.02089-17.

4.

Serum antibody response to Moraxella catarrhalis proteins in stringently defined otitis prone children.

Ren D, Almudevar AL, Murphy TF, Lafontaine ER, Campagnari AA, Luke-Marshall N, Pichichero ME.

Vaccine. 2019 Jul 26;37(32):4637-4645. doi: 10.1016/j.vaccine.2017.07.027. Epub 2017 Jul 26.

PMID:
28755833
5.

Magnesium alloy AZ91 exhibits antimicrobial properties in vitro but not in vivo.

Brooks EK, Ahn R, Tobias ME, Hansen LA, Luke-Marshall NR, Wild L, Campagnari AA, Ehrensberger MT.

J Biomed Mater Res B Appl Biomater. 2018 Jan;106(1):221-227. doi: 10.1002/jbm.b.33839. Epub 2017 Jan 27.

PMID:
28130825
6.

Host Physiologic Changes Induced by Influenza A Virus Lead to Staphylococcus aureus Biofilm Dispersion and Transition from Asymptomatic Colonization to Invasive Disease.

Reddinger RM, Luke-Marshall NR, Hakansson AP, Campagnari AA.

MBio. 2016 Aug 9;7(4). pii: e01235-16. doi: 10.1128/mBio.01235-16.

7.

Cathodic Voltage-controlled Electrical Stimulation Plus Prolonged Vancomycin Reduce Bacterial Burden of a Titanium Implant-associated Infection in a Rodent Model.

Nodzo SR, Tobias M, Ahn R, Hansen L, Luke-Marshall NR, Howard C, Wild L, Campagnari AA, Ehrensberger MT.

Clin Orthop Relat Res. 2016 Jul;474(7):1668-75. doi: 10.1007/s11999-016-4705-7.

8.

Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children.

Ren D, Almudevar AL, Murphy TF, Lafontaine ER, Campagnari AA, Luke-Marshall N, Casey JR, Pichichero ME.

Vaccine. 2015 Oct 26;33(43):5809-5814. doi: 10.1016/j.vaccine.2015.09.023. Epub 2015 Sep 21.

9.

Cathodic Electrical Stimulation Combined With Vancomycin Enhances Treatment of Methicillin-resistant Staphylococcus aureus Implant-associated Infections.

Nodzo S, Tobias M, Hansen L, Luke-Marshall NR, Cole R, Wild L, Campagnari AA, Ehrensberger MT.

Clin Orthop Relat Res. 2015 Sep;473(9):2856-64. doi: 10.1007/s11999-015-4280-3.

10.

Cathodic voltage-controlled electrical stimulation of titanium implants as treatment for methicillin-resistant Staphylococcus aureus periprosthetic infections.

Ehrensberger MT, Tobias ME, Nodzo SR, Hansen LA, Luke-Marshall NR, Cole RF, Wild LM, Campagnari AA.

Biomaterials. 2015 Feb;41:97-105. doi: 10.1016/j.biomaterials.2014.11.013. Epub 2014 Dec 5.

PMID:
25522969
11.

Moraxella catarrhalis is susceptible to antimicrobial photodynamic therapy with Photofrin.

Luke-Marshall NR, Mang TS, Hansen LA, Campagnari AA.

Lasers Surg Med. 2014 Nov;46(9):712-7. doi: 10.1002/lsm.22287. Epub 2014 Aug 22.

PMID:
25154610
12.

Characterization of a trifunctional glucosyltransferase essential for Moraxella catarrhalis lipooligosaccharide assembly.

Luke-Marshall NR, Edwards KJ, Sauberan S, St Michael F, Vinogradov EV, Cox AD, Campagnari AA.

Glycobiology. 2013 Aug;23(8):1013-21. doi: 10.1093/glycob/cwt042. Epub 2013 May 29.

13.

The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.

Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, St Michael F, Vinogradov EV, Spellberg B, Luke-Marshall NR, Campagnari AA.

Infect Immun. 2013 Mar;81(3):915-22. doi: 10.1128/IAI.01184-12. Epub 2013 Jan 7.

14.

The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells.

Brossard KA, Campagnari AA.

Infect Immun. 2012 Jan;80(1):228-33. doi: 10.1128/IAI.05913-11. Epub 2011 Nov 14.

15.

Comparative analysis and supragenome modeling of twelve Moraxella catarrhalis clinical isolates.

Davie JJ, Earl J, de Vries SP, Ahmed A, Hu FZ, Bootsma HJ, Stol K, Hermans PW, Wadowsky RM, Ehrlich GD, Hays JP, Campagnari AA.

BMC Genomics. 2011 Jan 26;12:70. doi: 10.1186/1471-2164-12-70.

16.

Comparative analyses of the Moraxella catarrhalis type-IV pilus structural subunit PilA.

Luke-Marshall NR, Sauberan SL, Campagnari AA.

Gene. 2011 May 15;477(1-2):19-23. doi: 10.1016/j.gene.2011.01.010. Epub 2011 Jan 20.

PMID:
21256201
17.

The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.

Russo TA, Luke NR, Beanan JM, Olson R, Sauberan SL, MacDonald U, Schultz LW, Umland TC, Campagnari AA.

Infect Immun. 2010 Sep;78(9):3993-4000. doi: 10.1128/IAI.00366-10. Epub 2010 Jul 19.

18.

Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis.

Luke NR, Sauberan SL, Russo TA, Beanan JM, Olson R, Loehfelm TW, Cox AD, St Michael F, Vinogradov EV, Campagnari AA.

Infect Immun. 2010 May;78(5):2017-23. doi: 10.1128/IAI.00016-10. Epub 2010 Mar 1.

19.

Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies.

Schwingel JM, Edwards KJ, Cox AD, Masoud H, Richards JC, St Michael F, Tekwe CD, Sethi S, Murphy TF, Campagnari AA.

Infect Immun. 2009 Oct;77(10):4548-58. doi: 10.1128/IAI.00294-09. Epub 2009 Aug 3.

20.

Comparative proteomic analysis of the Haemophilus ducreyi porin-deficient mutant 35000HP::P2AB.

Davie JJ, Campagnari AA.

J Bacteriol. 2009 Apr;191(7):2144-52. doi: 10.1128/JB.01487-08. Epub 2008 Dec 19.

21.

Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii.

Adams MD, Goglin K, Molyneaux N, Hujer KM, Lavender H, Jamison JJ, MacDonald IJ, Martin KM, Russo T, Campagnari AA, Hujer AM, Bonomo RA, Gill SR.

J Bacteriol. 2008 Dec;190(24):8053-64. doi: 10.1128/JB.00834-08. Epub 2008 Oct 17.

22.

Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology.

Russo TA, Beanan JM, Olson R, MacDonald U, Luke NR, Gill SR, Campagnari AA.

Infect Immun. 2008 Aug;76(8):3577-86. doi: 10.1128/IAI.00269-08. Epub 2008 Jun 9.

23.

A unique glycosyltransferase involved in the initial assembly of Moraxella catarrhalis lipooligosaccharides.

Schwingel JM, St Michael F, Cox AD, Masoud H, Richards JC, Campagnari AA.

Glycobiology. 2008 Jun;18(6):447-55. doi: 10.1093/glycob/cwn021. Epub 2008 Mar 12.

PMID:
18337458
24.

Identification and characterization of an Acinetobacter baumannii biofilm-associated protein.

Loehfelm TW, Luke NR, Campagnari AA.

J Bacteriol. 2008 Feb;190(3):1036-44. Epub 2007 Nov 16.

25.

Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation.

Luke NR, Jurcisek JA, Bakaletz LO, Campagnari AA.

Infect Immun. 2007 Dec;75(12):5559-64. Epub 2007 Oct 1.

26.

Identification of a novel two-partner secretion locus in Moraxella catarrhalis.

Plamondon P, Luke NR, Campagnari AA.

Infect Immun. 2007 Jun;75(6):2929-36. Epub 2007 Apr 9.

27.

Expression of OmpP2A and OmpP2B is not required for pustule formation by Haemophilus ducreyi in human volunteers.

Janowicz D, Luke NR, Fortney KR, Katz BP, Campagnari AA, Spinola SM.

Microb Pathog. 2006 Mar;40(3):110-5. Epub 2006 Jan 19.

PMID:
16426809
28.

Multiplex PCR assay that identifies the major lipooligosaccharide serotype expressed by Moraxella catarrhalis clinical isolates.

Edwards KJ, Schwingel JM, Datta AK, Campagnari AA.

J Clin Microbiol. 2005 Dec;43(12):6139-43.

29.
30.

Identification of a conserved Moraxella catarrhalis haemoglobin-utilization protein, MhuA.

Furano K, Luke NR, Howlett AJ, Campagnari AA.

Microbiology. 2005 Apr;151(Pt 4):1151-8.

PMID:
15817782
31.

Identification of a hemin utilization protein of Moraxella catarrhalis (HumA).

Furano K, Campagnari AA.

Infect Immun. 2004 Nov;72(11):6426-32.

32.

Differential expression of porins OmpP2A and OmpP2B of Haemophilus ducreyi.

Prather DT, Bains M, Hancock RE, Filiatrault MJ, Campagnari AA.

Infect Immun. 2004 Nov;72(11):6271-8.

33.
34.
36.

Characterization of lipooligosaccharides from Haemophilus ducreyi containing polylactosamine repeats.

Schilling B, Gibson BW, Filiatrault M, Campagnari AA.

J Am Soc Mass Spectrom. 2002 Jun;13(6):724-34.

PMID:
12056572
37.

The lbgAB gene cluster of Haemophilus ducreyi encodes a beta-1,4-galactosyltransferase and an alpha-1,6-DD-heptosyltransferase involved in lipooligosaccharide biosynthesis.

Tullius MV, Phillips NJ, Scheffler NK, Samuels NM, Munson Jr RS Jr, Hansen EJ, Stevens-Riley M, Campagnari AA, Gibson BW.

Infect Immun. 2002 Jun;70(6):2853-61.

40.

Haemophilus ducreyi lipooligosaccharide mutant defective in expression of beta-1,4-glucosyltransferase is virulent in humans.

Young RS, Filiatrault MJ, Fortney KR, Hood AF, Katz BP, Munson RS Jr, Campagnari AA, Spinola SM.

Infect Immun. 2001 Jun;69(6):4180-4.

41.

Lipooligosaccharide P(k) (Galalpha1-4Galbeta1-4Glc) epitope of moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum.

Zaleski A, Scheffler NK, Densen P, Lee FK, Campagnari AA, Gibson BW, Apicella MA.

Infect Immun. 2000 Sep;68(9):5261-8.

42.

Detection of biological threat agents by immunomagnetic microsphere-based solid phase fluorogenic- and electro-chemiluminescence.

Yu H, Raymonda JW, McMahon TM, Campagnari AA.

Biosens Bioelectron. 2000 Jan;14(10-11):829-40. Review.

PMID:
10945457
44.

Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers.

Young RS, Fortney K, Haley JC, Hood AF, Campagnari AA, Wang J, Bozue JA, Munson RS Jr, Spinola SM.

Infect Immun. 1999 Dec;67(12):6335-40.

45.
47.

Phase variation and conservation of lipooligosaccharide epitopes in Haemophilus somnus.

Inzana TJ, Hensley J, McQuiston J, Lesse AJ, Campagnari AA, Boyle SM, Apicella MA.

Infect Immun. 1997 Nov;65(11):4675-81. Erratum in: Infect Immun 1998 Aug;66(8):4010.

48.

Characterization of a transposon Tn916-generated mutant of Haemophilus ducreyi 35000 defective in lipooligosaccharide biosynthesis.

Gibson BW, Campagnari AA, Melaugh W, Phillips NJ, Apicella MA, Grass S, Wang J, Palmer KL, Munson RS Jr.

J Bacteriol. 1997 Aug;179(16):5062-71.

49.

Characterization of a novel lipoprotein expressed by Haemophilus ducreyi.

Hiltke TJ, Campagnari AA, Spinola SM.

Infect Immun. 1996 Dec;64(12):5047-52.

Supplemental Content

Loading ...
Support Center